An interventional study of Eye Drop Dispenser TYPE Opticare and Eye Drop Dispenser Autodrop in Glaucoma, Cataract and Healthy Subjects, sponsored by Wolfson Medical Center. Status unknown at 1 site in Israel. Per ClinicalTrials.gov, last updated 2018-05-01.
Sponsored by Wolfson Medical Center · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 27 studies in Glaucoma with a site in Israel — 1 open to participants now, 1 under way, none of them phase 3. Glaucoma · Israel.
Among the 27 studies in Glaucoma with a site in Israel, this one is the 11th largest by planned enrollment of the 17 interventional ones that give a count, is the only one that started in 2019, is one of 10 with no phase, and was the 27th registered.
1,419 studies on the registry are indexed under Glaucoma; 221 are open to participants now.
Browse Glaucoma studies →1 of the 27 studies in Glaucoma with a site in Israel is open now. Recruiting first, the newest first:
Sheba Medical Center · Sites in Israel
Ages 18–80 · Healthy volunteers
A study can be open while its sites in Israel have not opened yet or have stopped. Only those recruiting at a site in Israel →
Of the 155 Glaucoma studies recruiting now, 113 (73%) set no upper age limit and 9 (6%) stop at 75 or younger; 13 take children under 18; 44 take healthy volunteers.
This study: all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
27 studies; the count open now beside each. This study's row is marked.
First in 2004; this study’s year is marked. 1 started in 2019.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 50 is below the median of 61 across 964 interventional studies indexed under Glaucoma.
Median enrollment 80 across the 17 interventional studies, 100 across the 9 observational. Of the 16 that completed or were terminated, 3 (19%) have results posted.
This tab as a report to print or save as PDF → With an account.
10 of 27 have an industry lead sponsor. The 10 most frequent:
Wolfson Medical Center is the lead sponsor of 118 studies on the registry; 17 are open to participants now.
Wolfson Medical Center has 1 study filed under Glaucoma — fewer than ten, so there is no comparison to draw.
1 of the studies in Glaucoma with a site in Israel that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT02014389Sheba Medical CenterEvaluation of Objective Perimetry Using Chromatic Multifocal Pupillometer | 2026-12-31 |
Add it to your calendar (.ics) → With an account.
Among the 27 studies in Glaucoma with a site in Israel, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
One aspect to eye drop adherence is successful instillation of the drops; however, it is well known that many patients struggle with this task. Difficulties may include aiming their drops,extending their neck, preventing excess drop leakage, avoiding contamination of the bottle tip and generating enough force to expel a drop from the bottle. Instillation aids are devices that aim to ameliorate one or more of these barriers.
Several eye drop dispensers had been developed in order to improved outcomes of eye drop instillation, including improved rates of successful administration and increased patient satisfaction compared to standard eye drop bottles.
In this study we aim to compare the eye drops various installation aids
subject will evaluate 2 dispensers by questioners. efficacy and safety of each one will be evaluated.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
subject will assess TYPE 1 dispenser
Device: Eye Drop Dispenser TYPE Opticare
subject will assess Autodrop dispenser
Device: Eye Drop Dispenser Autodrop
Subject will apply normal saline eye drops to them-self with various eye drop dispensers. Assessment of ease of use will be conducted by questioners.
Eye Drop Dispenser Autodrop
Number of correct application of eye drops to the eye without missing conducted by questioners.
assessment of correct application of eye drops to the eye without missing
Time frame: 5 seconds after instillation of eye drops
Plan to share: Undecided
No publications or documents are linked to this record.
Start is estimated for Apr 2019; primary completion for Jan 2020, 9 months later.
Of 230 non-industry interventional studies with no phase under Glaucoma, half reached primary completion within 32 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 55. This study's planned 9 months is below that.
Counting every sponsor, half of 288 studies reached it within 30 months; a quarter within 12 and three quarters within 53.
How these figures are worked out, and which studies are left out of them.
This study is status unknown, as verified in Apr 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.